Axel Petzold
Axel Petzold
University College London, The National Hospital for Neurology and Neurosurgery & Moorfields Eye
Verified email at - Homepage
Cited by
Cited by
Neurofilaments as biomarkers in neurological disorders
M Khalil, CE Teunissen, M Otto, F Piehl, MP Sormani, T Gattringer, ...
Nature Reviews Neurology 14 (10), 577-589, 2018
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
CE Teunissen, A Petzold, JL Bennett, FS Berven, L Brundin, M Comabella, ...
Neurology 73 (22), 1914-1922, 2009
Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss
A Petzold
Journal of the neurological sciences 233 (1-2), 183-198, 2005
Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis
A Petzold, JF de Boer, S Schippling, P Vermersch, R Kardon, A Green, ...
The Lancet Neurology 9 (9), 921-932, 2010
The OSCAR-IB consensus criteria for retinal OCT quality assessment
P Tewarie, L Balk, F Costello, A Green, R Martin, S Schippling, A Petzold
PloS one 7 (4), e34823, 2012
Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis
CH Lu, C Macdonald-Wallis, E Gray, N Pearce, A Petzold, N Norgren, ...
Neurology 84 (22), 2247-2257, 2015
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
A Petzold, LJ Balcer, PA Calabresi, F Costello, TC Frohman, EM Frohman, ...
The Lancet Neurology 16 (10), 797-812, 2017
Increased neurofilament light chain blood levels in neurodegenerative neurological diseases
J Gaiottino, N Norgren, R Dobson, J Topping, A Nissim, A Malaspina, ...
PloS one 8 (9), e75091, 2013
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
G Pryce, Z Ahmed, DJR Hankey, SJ Jackson, JL Croxford, JM Pocock, ...
Brain 126 (10), 2191-2202, 2003
The APOSTEL recommendations for reporting quantitative optical coherence tomography studies
A Cruz-Herranz, LJ Balk, T Oberwahrenbrock, S Saidha, ...
Neurology 86 (24), 2303-2309, 2016
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study
EH Martinez-Lapiscina, S Arnow, JA Wilson, S Saidha, JL Preiningerova, ...
The Lancet Neurology 15 (6), 574-584, 2016
Myelin-oligodendrocyte glycoprotein antibody-associated disease
R Marignier, Y Hacohen, A Cobo-Calvo, AK Pröbstel, O Aktas, ...
The Lancet Neurology 20 (9), 762-772, 2021
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
A Abdelhak, M Foschi, S Abu-Rumeileh, JK Yue, L D’Anna, A Huss, ...
Nature Reviews Neurology 18 (3), 158-172, 2022
The investigation of acute optic neuritis: a review and proposed protocol
A Petzold, MP Wattjes, F Costello, J Flores-Rivera, CL Fraser, K Fujihara, ...
Nature Reviews Neurology 10 (8), 447-458, 2014
Axonal damage markers in cerebrospinal fluid are increased in ALS
J Brettschneider, A Petzold, SD Sussmuth, AC Ludolph, H Tumani
Neurology 66 (6), 852-856, 2006
Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria
S Schippling, LJ Balk, F Costello, P Albrecht, L Balcer, PA Calabresi, ...
Multiple sclerosis journal 21 (2), 163-170, 2015
Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations
A Petzold, MJ Eikelenboom, D Gveric, G Keir, M Chapman, RHC Lazeron, ...
Brain 125 (7), 1462-1473, 2002
Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage
J Sen, A Belli, H Albon, L Morgan, A Petzold, N Kitchen
The Lancet Neurology 2 (10), 614-621, 2003
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis
M Stangel, S Fredrikson, E Meinl, A Petzold, O Stüve, H Tumani
Nature Reviews Neurology 9 (5), 267-276, 2013
Optical coherence tomography reveals distinct patterns of retinal damage in neuromyelitis optica and multiple sclerosis
E Schneider, H Zimmermann, T Oberwahrenbrock, F Kaufhold, EM Kadas, ...
PloS one 8 (6), e66151, 2013
The system can't perform the operation now. Try again later.
Articles 1–20